GlaxoSmithKline (GSK) is partnering with the
The funding for the park, which is estimated at £38m, is being led by East of England Development Agency (EEDA).
GSK claims that the park could be an international hub for early-stage biotechnology companies. It is hoped that the campus will compete with those in
It is anticipated that, when complete, the new centre will be the base for approximately 1,500 scientists. GSK believes that any company located in the park will have shared access to specialist skills, equipment and expertise to stimulate innovation in drug development, increasing the chance of success.
‘The Stevenage Campus will affirm the
Business secretary Lord Mandelson said that the Stevenage Campus represents a huge investment in the future of
‘It will leverage our existing strengths as a world leader in the sector, helping it to grow and reinforcing our international competitiveness,’ he said. ‘And ultimately it will help us build towards a stronger
The Department for Business, Innovation and Skills has agreed to provide almost £11.7m and an additional £5m will come from the Technology Strategy Board. GSK will provide land, facilities and investment totalling almost £11m. The Wellcome Trust will provide almost £6m and the EEDA will provide £4m.